APOE Genotype and Fluid Biomarkers of Blood-Brain Barrier Integrity: A Systematic Review and Meta-Analysis
Lucas, W.; Murphy, M. J.; Riddell, N.
Show abstract
Apolipoprotein E (APOE) genotype is theorised to influence dementia risk partly through effects on blood-brain barrier (BBB) function, but clinical studies examining APOE effects on BBB biomarkers report inconsistent results. Therefore, this systematic review and meta-analysis quantified associations between APOE genotype and two commonly used fluid biomarkers of CNS barrier function: cerebrospinal fluid (CSF)/serum albumin quotient (Q-Alb), and soluble platelet-derived growth factor receptor beta (sPDGFRB). Ovid MEDLINE, Embase, and Web of Science were searched on 30th June, 2026. Eligible peer-reviewed human studies reported Q-Alb or blood or CSF sPDGFRB; by APOE genotype. Risk of bias was assessed using the Joanna Briggs Institute checklist. Twenty-eight studies involving 5,375 participants were included: 17 assessed Q-Alb and 11 assessed sPDGFRB. Random-effects meta-analyses determined that APOE e2 carriage was associated with higher Q-Alb (g = 0.29, 95% CI 0.11 to 0.46). APOE e4 carriage was not associated with Q-Alb overall (g = .13, 95% CI -.17 to .43) or sPDGFRB overall (g = .10, 95% CI -.21 to .40). Genotype-specific Q-Alb analyses suggested medium positive but non-significant effects among e4/e4 and e2/e4 carrier subgroups. For sPDGFRB, exploratory subgroup analysis revealed effect estimates near zero in cognitively unimpaired participants, and a small positive non-significant effect in cognitively impaired participants. Larger effects were also observed in samples with an older mean age, although this was not statistically significant. Overall, evidence for APOE e4-associated alterations in Q-Alb and sPDGFRB remained inconclusive, highlighting the need for further study across the spectrum of cognitive ageing and dementia. In contrast, APOE e2 carriage was associated with greater barrier dysfunction as indexed by Q-Alb, broadening the predominant focus on APOE e4 and identifying e2 as a potentially important but understudied contributor to altered neurovascular function.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Relationships of hematocrit concentration with dementia from a multiethnic population-based study 92%
- Exploring Cognitive and Neuroimaging Profiles of Dementia Subtypes of Individuals with Dementia in the Democratic Republic of Congo 92%
- Phenotyping Neuropsychiatric Symptoms Profiles of Alzheimer's Disease Using Cluster Analysis on EEG Power 91%
Similar papers in this journal
- The contribution of Apoliproprotein E genetic variation to dementia risk in British South Asians 93%
- The PREVENT Dementia programme: Baseline demographic, lifestyle, imaging and cognitive data from a midlife cohort study investigating risk factors for dementia 93%
- Alzheimer's disease biomarker profiling in a memory clinic cohort without common comorbidities 93%
Similar papers in this journal
- Genetic risk for Alzheimer disease, cognition and Mild Behavioral Impairment in healthy older adults 93%
- The Temporal Relationships between White Matter Hyperintensities, Neurodegeneration, Amyloid β, and Cognition 92%
- Self-reported word-finding complaints are associated with cerebrospinal fluid beta-amyloid and atrophy in cognitively normal older adults 92%
Similar papers in this journal
- Association of long-term body weight variability with dementia: a prospective study 93%
- Plasma Level of ATPase Inhibitory Factor 1 (IF1) and intrinsic capacity in community-dwelling older adults: Prospective data from the MAPT Study 92%
- Differences in AD-related pathology profiles across APOE groups 92%